Genetic factors in smoking also increase risk of chronic bronchitisFebruary 29, 2008Smoking is a known risk factor for respiratory diseases like chronic bronchitis, but genes also play a significant role in its development, according to researchers in Sweden, who studied more than 40,000 Swedish twins to determine the extent to which behavior, environment and genes each play a role ion the development of chronic bronchitis. "[S]moking behavior has a known genetic component and smoking is a primary risk factor for chronic bronchitis," wrote Jenny Hallberg, of the Department of Public Health Sciences at Karolinska Institutet in Stockholm. Hereditability accounted for 40 percent of the risk for chronic bronchitis, but, interestingly, 14 percent of the genetic risk was also linked to a genetic predisposition to smoke, whether or not the individual actually smoked. Chronic bronchitis along with emphysema account for most cases of chronic obstructive pulmonary disease, or COPD. The research was published in the first issue for March of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. The researchers analyzed data from the Screening Across Lifespan Twin (SALT) study in Sweden, which surveyed all known living twins in Sweden born in 1958 or earlier. The survey included questions on zygosity-whether the twins shared 100 or 50 percent of their genetic material-smoking history and a checklist of common diseases. The interview asked specific screening questions designed to determine whether the interviewee had chronic bronchitis. The investigators used the survey data and statistical modeling to tease apart the genetic and environmental influences that comprise an individual's risk of developing chronic bronchitis: genetic factors, shared environmental factors (i.e., experienced by both twins) and non-shared environmental factors. "[This] study on the population-based Swedish Twin Registry, showing a genetic effect for the development of chronic bronchitis that does not differ by sex is the first to our knowledge to quantify heritability of the disease," she said. Because chronic bronchitis had previously been reported to be more prevalent in women than men, the results pointed to a number of intriguing possibilities. "It is possible that women are more prone to report symptoms," remarked Dr. Hallberg. "Or, more likely, this could be an effect of smoking being more harmful for women due to their smaller lungs from start (exposure to cigarette smoke relative to body size)." Dr. Hallberg cautioned that the finding that the genetic factors that contribute to chronic bronchitis were largely independent of those that contribute to smoking should not be interpreted to mean that smoking has no effect on chronic bronchitis. "Although there was some genetic interplay, it is safe to say that smoking itself, and not the genes that predispose one to smoking, is a larger risk factor in developing chronic bronchitis of environmental exposures-- primarily smoking-- than genetic predisposition. This is true of both men and women," said Dr. Hallberg. The investigators are currently working on a clinical follow-up study that is relating clinical measures of lung function to obstruction. "We believe that it is important to also include testing of lung function to disentangle whether there are genetic differences by sex," said Dr. Hallberg. "There is also data in the literature that social factors have different importance for smoking behavior in men and women. We know much less regarding the genetic influences." American Thoracic Society |
|||||||||||||||||||||
| Related Chronic Bronchitis Current Events and Chronic Bronchitis News Articles Survey: Awareness of COPD is rising, but understanding is still low Awareness of COPD-chronic obstructive pulmonary disease-continues to grow in the United States, according to national survey results released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Safety, efficacy of corneal transplant procedure confirmed; an antibiotic can cause double vision Highlights of September's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), include a 2009 review by the Academy of the safety and efficacy of a widely used corneal transplant procedure and a warning about an unusual but serious reaction to systemic fluroquinolones, a class of antibiotics used to treat a variety of bacterial infections. Scientists open doors to diagnosis of emphysema Chronic inflammatory lung diseases like chronic bronchitis and emphysema are a major global health problem, and the fourth leading cause of death and disability in developed countries, with smoking accounting for 90% of the risk for developing them. Scientists expect wildfires to increase as climate warms in the coming decades As the climate warms in the coming decades, atmospheric scientists at Harvard's School of Engineering and Applied Sciences (SEAS) and their colleagues expect that the frequency of wildfires will increase in many regions. Supervised exercise therapy can lead to improvements in COPD symptoms Those suffering from chronic obstructive pulmonary disease (COPD) often complain that exercise is too exhausting and leaves them breathless. New discovery paves the way for new diagnosis of serious lung disease The discovery by Uppsala University researchers of a previously unknown protein in the cells of the lower air ways brings new potential for early diagnosis of a serious lung disease. Activating the lung's antioxidant defense by targeting Nrf2 inhibits the development of emphysema Using a molecule similar to one found in an experimental cancer drug, researchers at the Johns Hopkins Bloomberg School of Public Health demonstrated that activation of a key component of the lung's antioxidant defense system, Nrf2, can prevent emphysema in mice. Wheezing and asthma in young children The diagnosis of asthma in a young child may well be more challenging to pediatricians than previously appreciated, according to a review of research and clinical experience literature by Howard Eigen, M.D., of the Indiana University School of Medicine and Riley Hospital for Children appearing in the October 2008 issue of Clinical Pediatrics. Common bronchodilator linked to increased deaths A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease (COPD) has been linked to a one-third higher risk of cardiovascular-related deaths. Low level cadmium exposure linked to lung disease New research suggests that cadmium is one of the critical ingredients causing emphysema, and even low-level exposure attained through second-hand smoke and other means may also increase the chance of developing lung disease. More Chronic Bronchitis Current Events and Chronic Bronchitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||